参芪扶正注射液在晚期NSCLC患者化疗中的辅助作用
|
摘要
目的分析参芪扶正注射液在晚期NSCLC患者化疗中的辅助作用。方法选取2017年1月至2018年6月收治的晚期NSCLC患者56例为研究对象,随机列表法分为对照组28例进行单纯化疗,观察组28例,在化疗基础上采用参芪扶正注射液治疗,对比两种治疗方式效果。结果两组患者临床疗效无较大差异,差异无统计学意义(P>0.05);观察组患者生活质量更好,数据差异显著(P<0.05);对照组患者血红蛋白、白细胞下降程度更多,差异较大(P<0.05),血小板降低程度无较大差异(P>0.05)。结论为晚期NSCLC患者予以化疗基础上的参芪扶正注射液治疗时临床疗效较好,且不良反应少,有应用价值。
Objective To analyze adjuvant effect of Shenqi Fuzheng Injection on advanced NSCLC chemotherapy patients. Methods Choose 56 cases advanced NSCLC patients admitted from January 2017 to June 2018 as research objects. 28 cases in control group were treated with chemotherapy only and 28 cases in observation group with Shenqi Fuzheng injection on the basis of chemotherapy. Compare effects of two treatment methods. Results Clinical effect difference showed no statistical significance between two groups(P> 0.05). Life quality of observation group was better with significant data difference,(P<0.05). Decrease of hemoglobin and white blood cells in control group was more significant, with significant difference(P<0.05), decrease of platelet showed no significant difference,(P>0.05).Conclusion Shenqi Fuzheng Injection has good clinical effect and fewer adverse reactions for advanced NSCLC patients based on chemotherapy, which is of practical value.
Objective To analyze adjuvant effect of Shenqi Fuzheng Injection on advanced NSCLC chemotherapy patients. Methods Choose 56 cases advanced NSCLC patients admitted from January 2017 to June 2018 as research objects. 28 cases in control group were treated with chemotherapy only and 28 cases in observation group with Shenqi Fuzheng injection on the basis of chemotherapy. Compare effects of two treatment methods. Results Clinical effect difference showed no statistical significance between two groups(P> 0.05). Life quality of observation group was better with significant data difference,(P<0.05). Decrease of hemoglobin and white blood cells in control group was more significant, with significant difference(P<0.05), decrease of platelet showed no significant difference,(P>0.05).Conclusion Shenqi Fuzheng Injection has good clinical effect and fewer adverse reactions for advanced NSCLC patients based on chemotherapy, which is of practical value.
引文
[1]赵彩霞.参芪扶正注射液联合吉西他滨、顺铂方案治疗晚期NSCLC前瞻性临床对照研究[J].海峡药学,2016,28(4):159-161.
[2]贵永贤,田国防.参芪扶正注射液联合吉西他滨、顺铂方案治疗晚期NSCLC前瞻性随机临床对照研究[J].中国处方药,2016,14(7):53-54.
[3]徐凯丽,杨珺超,韩佳颖,等.参芪扶正注射液联合化疗对晚期非小细胞肺癌患者免疫功能影响的Meta分析[J].中国现代应用药学,2016,33(3):352-359.
[4]姜孝娟,黄勇,张丽娟.参芪扶正注射液在晚期胃癌化疗中应用观察[J].安徽卫生职业技术学院学报,2016,15(3):59-60.
[2]贵永贤,田国防.参芪扶正注射液联合吉西他滨、顺铂方案治疗晚期NSCLC前瞻性随机临床对照研究[J].中国处方药,2016,14(7):53-54.
[3]徐凯丽,杨珺超,韩佳颖,等.参芪扶正注射液联合化疗对晚期非小细胞肺癌患者免疫功能影响的Meta分析[J].中国现代应用药学,2016,33(3):352-359.
[4]姜孝娟,黄勇,张丽娟.参芪扶正注射液在晚期胃癌化疗中应用观察[J].安徽卫生职业技术学院学报,2016,15(3):59-60.